Skip to main content
TDAC logo

TDAC · Translational Development Acquisition Corp. · Metrics

Track TDAC — free
$10.86 -0.04 (-0.37%) At close · Sep 11
Market Cap
$209.69M
Shares
19.31M

TDAC metrics

43 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.86
Market cap
$209.69M

Price action

20 metrics
Price change (1W)
+0.1%
Price change (30D)
+0.1%
Price change (3M)
+1.3%
Price change (6M)
+3.0%
Price change (YTD)
+3.5%
Price change (1Y)
+5.0%
Trailing year
Price change (5Y)
52-week high
$10.90
52-week low
$10.34
Change from 52-week high
-0.4%
Change from 52-week low
+5.0%
Annualized volatility
3.0%
Annualized volatility (3M)
2.7%
Beta
0.0
RSI (14D)
55.3
Price vs SMA 50
+0.5%
Price vs SMA 200
+2.7%
Avg volume (3M)
38,780
Relative volume
0.4
Average dollar volume
$419,195

Company

3 metrics
Sector
Financial Services
Industry
Shell Companies
Shares outstanding
19.31M

Valuation

12 metrics
P / E (TTM)
37.9
Trailing earnings · reciprocal yield 2.6%
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
P / book
FCF yield
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
2.6%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings

Profitability

9 metrics
Gross margin
Operating margin
Trailing 12 months
Net margin
Gross profit (TTM)
Operating profit (TTM)
−$1.32M
Net income (TTM)
$5.54M
Trailing 12 months
Diluted EPS (TTM)
FCF margin
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share

Growth

11 metrics
Revenue growth YoY
Year over year
Net income growth YoY
-41.7%
Revenue (TTM)
Trailing 12 months
EPS growth YoY
Shares change YoY
Year over year · more shares
Revenue CAGR (3Y)
Revenue CAGR (5Y)
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
Return on assets
3.5%
Debt / equity
Current ratio
0.1
EBITDA (TTM)
Free cash flow (TTM)
Quick ratio
0.1
Interest coverage
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
$85,877
Latest balance sheet
Cash & equivalents
$85,877
Total assets
$157.37M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$849,378
Capital expenditures (TTM)
R&D (TTM)
SG&A (TTM)
Stock compensation (TTM)
R&D / revenue
Stock compensation / revenue

Ownership (13F)

3 metrics
13F filers
48
13F filer change QoQ
-6
Institutional ownership
112.0%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
46 / 100

Insider activity

2 metrics
Net insider buying (90D)
Insider-sentiment score

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1926599 CUSIP G9008W105 13F (30d) 23 filings 23 filers Visit website